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PICOT Question 
Are chronic pain patients who have either neuropathic pain or nociceptive 
(musculoskeletal) pain at an increased risk for neurologic grey matter atrophy compared with 
people without chronic pain within 0-14 months of the start of each study discussed below?  
Introduction 
Pain is felt by all humans, however only a portion of the population develops a chronic 
pain syndrome (Rodriquez-Raecke, et. al, 2013). Though the reason for this is unclear, the 
effects of chronic pain on the brain are becoming more evident. In the sections to follow there 
are a few examples of the many different types of chronic pain syndromes. Each of these 
examples seek to determine whether grey matter atrophy can be found in the brains of chronic 
pain patients. One study found that patients with neuropathic pain had significantly decreased 
grey matter volume in the anterior insula, primary somatosensory cortex, and thalamus on the 
side ipsilateral to the ongoing pain when compared with control subjects (Henderson et., al, 
2013). Another article explored the effects of the reversible chronic pain caused by hip 
osteoarthritis (OA). Over the course of the longitudinal study, the researchers noted changes in 
neurologic grey matter in patients with hip OA which were partially reversed when the patient 
was free of chronic pain post orthopedic surgery (Rodriquez-Raecke, et. al, 2013). As the 
alterations in grey matter were partially reversible, the authors believe that atrophy is not 
responsible for the differences seen in pain subjects. On the other hand, a study of chronic back 
pain (CBP) patients determined that grey matter atrophy of the brain in CBP is equal to 10-20 
years of normal aging, with normal grey matter atrophy occurring at a rate of 0.5% per year 
(Apkarian, et. al, 2004). A fourth study examined the brains of patients diagnosed with chronic 
regional pain syndrome after trauma to a limb or other portion of the body. These patients were 
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found to have a distinct area of atrophy in the ventromedial prefrontal cortex (VMPFC), an area 
involved in the processing of pain intensity and duration (Geha, P. Y, et. al, 2008). Finally, 
Obermann et. al (2013) determined that trigeminal neuralgia patients showed an alteration in 
grey matter in several areas of the brain as compared to healthy controls. Thus, it is clear, chronic 
pain patients experience some type of neurological alteration in their grey matter. Chronic pain is 
difficult to manage, and can be detrimental to the quality of life of affected patients. As such, 
research and understanding of this topic is essential for nurses in clinical practice.  
Collection of Evidence 
 In order to answer the PICOT question, sources were compiled using two different 
databases: Academic Search Premier and PubMed. In the search for relevant articles, the 
keywords used were, “chronic pain,” “chronic pain syndromes,” “grey matter,” “atrophy,” 
“neuropathic,” and “nociceptive.” Exclusion criteria included studies that examined patients 
outside of the 0-14 month window. There are many different types of illnesses that can be 
classified as chronic pain syndromes, and so disease processes that did not fall under either 
neuropathic or nociceptive were also excluded.  
Synthesis and Review: Types of Chronic Pain and Their Causes 
Involvement of the Thalamus in Neuropathic pain  
 Four decades ago researchers suggested that neuropathic pain may be controlled in a 
distinct central location, possibly located in the thalamus. Henderson et., al. (2013), explored the 
more detailed hypothesis that neuropathic pain will be associated with volume loss in the ventral 
posterior thalamus, decreased thalamic reticular nucleus (TRN) blood flow, as well as decreased 
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GABAergic content1 of the thalamus, and altered connectivity. In order to look at the anatomy, 
connectivity, chemistry, and activity of the thalamus, the researchers used voxel-based 
morphometry2 (VBM), quantitative arterial spin labeling3, magnetic resonance spectroscopy, and 
functional MRI technology.  
 
Figure 1. Different views of the thalamus highlighting the various nuclei (Thomas, et. al, 2017). 
 The sample recruited for this study consisted of 23 participants suffering from trigeminal 
neuropathy and 43 pain free control subjects (Henderson et., al, 2013). The neuropathic pain 
                                                 
1 Decreased GABAergic content of the thalamus results in a decreased inhibitory effect causing an increase in 
connectivity.  
2
 Voxel-based morphometry: method of comparing the local concentration of grey matter between two groups of 
subjects (Ashburner & Friston, 2000).  
3
 Quantitative arterial spin labeling: MRI-based technique used to take quantitative blood flow measurements in 
arteries (Williams, 2016).   
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group were diagnosed using the same specific criteria, and were asked to keep a pain diary for 
the week leading up to their MRI scans. The pain levels recorded in the diary were averaged and 
used to determine if there was a relationship between the pain level and the long term grey 
matter volume of the participant’s brain.  
 When analyzing the results of VMB techniques, Henderson and his team added the age, 
gender, and total brain size of the participant as nuisance variables (Henderson et., al, 2013). 
They found that neuropathic pain participants had significantly decreased grey matter volume in 
the anterior insula, primary somatosensory cortex, and thalamus on the side ipsilateral to the 
ongoing pain. It was also found that there was a reduced grey matter volume in the contralateral 
thalamus in the pain subjects. Furthermore, 18 of neuropathic pain participants were found to 
have significantly decreased cerebral blood flow (CBF) to the contralateral thalamus and primary 
somatosensory cortex. The decrease in CBF was found to be in the vicinity of the TRN on the 
lateral side of the thalamus. Additionally, it was found that the greater the ongoing pain of the 
person, the greater the reduction in TRN blood flow. 
 
Figure 2. Connectivity of the insular cortex (Gogolla, 2017) 
 Results also showed that neuropathic pain participants had significantly lower GABA 
levels in the thalamus as compared with the control group (Henderson et., al, 2013). The 
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researchers noted that the subjects who were regularly taking pain medication had no significant 
difference in the GABA content of the thalamus compared to those who took no analgesic 
medication. In 12 of the neuropathic pain group participants, it was found that the thalamic 
GABA content was significantly negatively correlated with the connectivity of the ventral 
posteromedial nucleus (VPN) in both sides of the primary somatosensory/motor cortex. 
Therefore, in the participants with chronic pain, the greater the decrease in GABA content, the 
greater the variation in thalamocortical connectivity.  
In recent years, it has been hypothesized that neuropathic pain results from an alteration 
of activity in the thalamus (Henderson, et. al, 2013). Evidence has shown that neuropathic pain is 
consistently associated with a decrease in thalamic activity on the side contralateral to the 
chronic pain. Additionally, chronic neuropathic pain has been found to be associated with 
reduced blood flow within the TRN, and significant reduction in grey matter volume in the 
somatosensory thalamus. There is also a positive correlation between reduction of blood flow to 
the TRN and intensity of the neuropathic pain.  
 The data collected in this study supports the hypothesis that after a peripheral nerve 
injury, the loss of thalamic somatosensory grey matter results in a change in TRN activity, 
causing reduced GABA activity, and an altered thalamocortical connectivity (Henderson, et. al, 
2013). The effect of these three changes for some patients is ultimately a constant perception of 
pain. Currently, the mechanism attributed to decreased VP thalamic volume is unknown. 
However, it is known that blocking neuronal cell apoptosis using a caspase inhibitor after a nerve 
injury can prevent neuronal loss and reduce pain behaviors in animal models (Scholz, et. al, 
2005). Therefore, this research raises the possibility that preventative treatment could be utilized 
in the future to prevent the development of chronic pain after a peripheral nerve injury.  
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 This study directly relates to the PICOT question as it explored patients experiencing 
neuropathic pain and determined that there was a significant grey matter volume loss in the 
experimental group compared to the control group. This study is informative, well organized, 
and relevant. The results are reported in a manner that is clear and easy to follow. One limitation 
of this study is the sample size. The experimental group consisted of 23 people, and the control 
group contained 43 people. Though this is a large enough sample to produce a clear pattern, it 
may not be large enough to allow this data to be generalized to the whole of the chronic pain 
population.  
Structural Brain Changes in Chronic Pain 
 In this study, the authors explored one of the few chronic pain syndromes that is highly 
reversible: OA of the hip. This condition is considered curable as many patients are pain free 
after recovering from the acute pain that follows a total hip replacement (THR). The sample 
consisted of 20 patients who had hip OA in one of their hips (Rodriquez-Raecke, et. al, 2013). 
The group was seen at four different intervals: preoperatively, 6-8 weeks, 12-18 weeks and 10-14 
months postoperatively. All the patients involved in the study had chronic pain lasting longer 
than 12 months, and all were otherwise healthy. MRI scans were done at each appointment (4 
total for each participant) to analyze regional differences in grey matter.  
 All patients were recorded as experiencing chronic hip pain prior to the surgery 
(Rodriquez-Raecke, et. al, 2013). However, after the surgery, all were free of chronic pain, and 
were instead feeling the acute pain of the THR. Compared to healthy controls, the preoperative 
scan of patients with hip OA showed a reduction of grey matter in the anterior cingulate cortex 
(ACC), the dorsolateral prefrontal cortex (DLPFC), the insular cortex, the right temporal pole, 
and the cerebellum (Figure 3). In conducting a longitudinal analysis, the researchers found that 
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there was a significant increase in the grey matter of the ACC, insular cortex, and cerebellum 
from comparing scan 1 (preoperative) and scan 2 (6-8 weeks post-operative) to scan 3 (12-18 
weeks post-operative) and scan 4 (10-14 months postoperative).  
 
Figure 3. Statistical Parametric maps demonstrating the structural differences in grey matter in 
patients with chronic pain due to primary hip OA compared to controls and longitudinally 
compared to themselves over time (Rodriquez-Raecke, et. al, 2013). 
 
 Overall, the researchers noted changes in neurologic grey matter in patients with hip OA 
which were partially reversed when the patient was free of chronic pain post orthopedic surgery 
(Rodriquez-Raecke, et. al, 2013). The data suggests that the decrease in grey matter during a 
chronic pain state is not a result of any damage or atrophy to neuronal cells. The authors note 
that not all areas of decreased grey matter recovered, but suggested that the time spent in the 
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chronic pain state could affect the time it takes to reverse the changes. In addition, researchers 
also saw changes to the motor and premotor areas possibly due to patients requiring less 
restriction in mobility. It is unknown if this variable could have an impact on the grey matter 
density.  
 This study related directly to the PICOT question as the patients who were evaluated for 
grey matter decrease were experiencing chronic musculoskeletal pain. The authors provide 
evidence that brain grey matter does not atrophy in a chronic pain state. The article was clear and 
well written; however, the experimental design was broad. The researchers did not aim to 
discover what factors might change the brain in chronic pain, they focused solely on the 
neuroplasticity of the brain. It would be interesting to see the results of a scan 5 and scan 6 of the 
same patients in this study to see if the decrease in atrophy continued to reverse. Though the data 
presented was significant, this study was limited by a sample size of 20 participants.  
Chronic Back Pain (CBP) 
 Back pain makes up 25% of all disabling workplace injuries and is particularly prevalent 
among healthcare workers (Apkarian, et. al, 2004). Prior to this study, chronic pain has been 
studied by investigating changes in the nervous system in animal models. These studies found a 
reorganization of nociceptive stimuli perception and indicate the occurrence of apoptosis of 
spinal cord cells. It was previously assumed that the effects of chronic pain were reflected onto 
the cerebral cortex, but that the cerebral cortex would return to its previous state after the 
termination of the pain. However, the authors of this study hypothesized that in CBP, neocortical 
grey matter would atrophy at a rate that is beyond that of normal aging. Based on previous 
research, the researchers also hypothesized that the thalamus would also atrophy. Both 
hypotheses were confirmed by the data collected.  
THE BRAIN AND NERVOUS SYSTEM IN CHRONIC PAIN Simon 10
 The authors compared a study group of 26 CBP patients, with a control group of 26 
volunteers (Apkarian, et. al, 2004). CBP patients were diagnosed by experienced practitioners 
with the most current guidelines from the International Association for the Study of Pain (IASP). 
Causes of the CBP were not identified, however 15 patients were identified as having 
musculoskeletal pain, 5 had radiculopathic (neuropathic) pain, and 6 had a mixture of the two. 
All participants were given brain MRI scans, and the images were used determine normalized 
cortical grey matter volume, and normalized lateral ventricular volumes. VBM was used to 
evaluate grey matter density of specific regions. Pain, anxiety, and depression were determined 
using a 0-10 scale and questionnaires.  
 Result analysis indicated that the grey matter volume of the whole brain was dependent 
on age, gender, and duration of pain (Apkarian, et. al, 2004). After correcting for these 
confounding variables, CBP patients were found to have an 11% grey matter volume decrease 
compared to the control group. In CBP patients, it was found that bilaterally, the DLPFC was the 
main location for regional decrease in grey matter. Additionally, the CBP group showed a 
significant decrease in grey matter density in the right anterior thalamus. Based on pain changes 
in DLPFC, the authors concluded that the grey matter changes are strongly related to the 
characteristics of pain. Specifically, the neuropathic CBP patients were found to have a larger 
decrease in DLPFC density compared to the CBP patients with musculoskeletal pain. Finally, 
lateral ventricle analysis concluded that lateral ventricle size and pain intensity have a 
statistically significant positive correlation. Negative affectivity and sensory components of CBP 
we also found to have a positive correlation with the change in lateral ventricle size.  
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Figure 4. Schematic of major anatomical subdivisions in the frontal lobes (Badre, 2008). 
 In their discussion, the authors note that only a histological analysis could confirm the 
presence of atrophy in spinal cord cells (Apkarian, et. al, 2004). However, based on the 
magnitude of brain volume in participants, they could conclude that grey matter atrophy of the 
brain in CBP is equal to 10-20 years of normal aging, with normal grey matter atrophy occurring 
at a rate of 0.5% per year. Apkarian, et. al noted that in their data, only 18% of inconsistency in 
grey matter could be attributed to pain duration. This implies that there are other variables such 
as environment and genetics that contribute to the atrophy seen in these patients. The scientists 
note that some of the decrease in grey matter could be due to shrinking tissues as a result of an 
increase in extracellular volume. If this is the case, proper treatment could reverse this process. 
However, the decrease in grey matter could be a result of neurodegeneration. The authors feel as 
though the latter is the more likely option as the DLPFC does show decreased N-acetyl-aspartate 
(which is a phenomenon noted in most neurodegenerative processes).  
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 Based on the finds of their research, the authors could infer other relationships resulting 
in neurological changes (Apkarian, et. al, 2004). Though CBP is often associated with anxiety 
and depression, the pattern of atrophy observed is much different than that of anxiety and 
depression. Therefore, this pattern appears to be unique to CBP, particularly since the DLPFC 
and thalamus are involved in the perception of pain. Recent research on the DLPFC showed a 
limiting effect on the amount of pain perceived in the cortex. Therefore, atrophy in this region 
could alter the perception of pain states in chronic pain patients. The authors end by further 
suggesting that atrophy to the neurologic signals responsible for pain perception could impose on 
the characteristics of the pain state, leading it to become more permanent, and less treatable. 
 This study directly relates to the PICOT question as the findings presented significant 
grey matter loss in the brain, particularly in the DLPFC. This study is organized in a clear and 
concise manner. The results and discussion are well organized, and the discussion expands nicely 
on the implications of this research. Like the previous study, this article has a small sample size. 
The experimental group consisted of 26 people, and the control group contained 26 people. 
Though it is clear that the data obtained is statistically significant, I believe a larger sample size 
would be valuable.  
Complex Regional Pain Syndrome (CRPS) 
 CRPS most commonly develops after trauma or injury to a limb (Geha, P. Y, et. al, 
2008). The condition is characterized by an inflammatory or neuropathic response, and presents 
with painful sensations that are often exaggerated, abnormal blood flow to the region, diuresis, 
edema, disruption of motor function, and other changes to the skin and subcutaneous tissues. 
CRPS develops in only 5% of limb trauma cases, but can be debilitating to those who experience 
it.  
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 In this study, researchers examined the structure of the brain in patients with CRPS using 
VBM (Geha, P. Y, et. al, 2008). Additionally, the authors studied the relationship between grey 
matter atrophy and changes in connectivity of the white matter using diffusion tensor magnetic 
resonance imaging and made efforts to explain the clinical presentation of CRPS. Prior research 
has shown that CRPS patients perform poorly on emotional decision making tasks compared to 
CBP patients. The impairment of the CRPS patients is similar to that seen in patients with lesions 
in the VMPFC. Therefore, based on previous findings, this group of researchers hypothesized 
that CRPS can be defined by atrophy of grey matter in the VMPFC (Figure 5). Participants in 
this study included a group of 26 CRPS patients, and a control group of 28 healthy individuals. 
The pain group was diagnosed with CRPS using criteria defined by the IASP.  
 
Figure 5. 3-D projection of a transparent brain showing regions of activation: the ventral medial 
prefrontal cortex (vmPFC) is in red, and the DLPFC is in green (Oliwenstein, L., 2009). 
 
Ultimately, the study found no difference in neocortical grey matter volume or lateral 
ventricle size between CRPS patients, and the healthy control group (Geha, P. Y, et. al, 2008). 
However, whole-brain skeletal fractional anisotropy4 (FA) revealed a significant positive 
                                                 
4
 Whole-brain skeletal FA: measure of the diffusion of water across the white matter of the brain reflecting the 
integrity of the white matter (Geha, P. Y, et. al, 2008).  
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correlation with grey matter volume of the whole brain in healthy control subjects. The 
researchers evaluated this data as evidence for a disruption in the relationship between grey and 
white matter in CRPS patients. In the imaging of the regional grey matter of the VMPFC in 
CRPS patients, it was observed that there is a small area of atrophy containing the right VMPFC, 
a portion of the agranular insular area (AI), and the nucleus accumbens (NAc). Additionally, the 
CRPS patients exhibited a localized decrease in white matter anisotropy, as well as alterations in 
connectivity between white and grey matter regions. The data presented clearly showed a 
disruption in the relationship between white matter skeletal FA, and grey matter volume in CRPS 
patients. The scientists inferred a reorganization of white matter connections on a whole brain 
level in a manner that differs completely from that of the healthy subjects.  
One of the goals of this study was to use the data acquired to help explain some of the 
clinical presentations of CRPS (Geha, P. Y, et. al, 2008). The atrophy noted in clinical subjects 
in the right VMPFC, a portion of the AI, and the (NAc)was found to be related to pain duration 
and pain intensity. When these three separate anatomical regions were divided, the atrophy in the 
AI related specifically to the duration of the pain response as it is one of the parts of the brain 
that is most activated in result to acute pain. The interaction between pain intensity and duration 
was found to be directly related to atrophy in the VMPFC suggesting that the “emotional load 
(Geha, P. Y, et. al, 2008)” of CRPS falls on the VMPFC. This finding supported the main 
hypothesis of this study. In contrast to CBP patients showing atrophy of the thalamus and the 
DLPFC, CRPS patients do not show an increase in performance on emotional decision making 
tasks when a temporary reduction in pain in achieved. CBP patients however, show improvement 
and learning of these tasks over a period of time. This comparison suggests that the differences 
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in the regions of atrophy lie beneath the ability of a patient to perform emotional decision 
making tasks.  
The results of this study are directly related to the PICOT question, as specific areas of 
grey matter atrophy were found to be the result of CRPS. Like the articles preceding it, the sizes 
of the pain and control groups were small, however the results achieved were found to be 
statically significant. The way this article is organized and written made it a challenging read. 
The experimental procedures section is located after the conclusion, and many statements 
thorough the article could be written in a more concise manner. 
Grey Matter Reduction in Trigeminal Neuralgia (TN) 
 Traditionally, TN is thought to be a result of compression of the trigeminal nerve in the 
root entry zone close to the brainstem (Obermann, et. al, 2013). Researchers debate the presence 
of central involvement, but recent findings have pointed towards central grey matter loss in TN 
patients. The objective of this study was first to discover which areas of the brain are involved in 
the development and continuation of TN pain by comparing grey matter volume in TN and 
healthy subjects. Second, the researchers hoped to determine the differences between TN patients 
with persistent background pain and those with intermittent neuralgic attacks.  
 The sample size consisted of 60 TN patients from the same headache center recruited 
between 2007 and 2010 (Obermann, et. al, 2013). Diagnosis of TN was confirmed per the 
standards set by the International Classification of Headache Disorders (ICHD). None of the 
patients had any other remarkable neurological history or been treated invasively for TN. The 
pain group was compared to 49 healthy controls. Data was obtained through VBM imaging, and 
all images we evaluated by an experienced neuro-radiologist.  
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 Cross sectional data analysis displayed regional discrepancy in grey matter volume 
between TN patients and healthy subjects (Obermann, et. al, 2013). The pain group was noted to 
have decreased brain matter in the primary somatosensory cortex, orbitofrontal cortex, anterior 
cingulate cortex, insula, secondary somatosensory cortex, thalamus, putamen, caudate nucleus, 
DLPFC, and cerebellum (Figure 6). The comparison between the two different TN groups 
showed no differences. 
  
Figure 6. Structural brain changes related to trigeminal neuralgia associated facial pain 
(Obermann, et. al, 2013). 
 
 The regions in which grey matter reduction was noted are areas that have known 
connections with the processing and perception of pain (Obermann, et. al, 2013). The researchers 
also note that their findings on grey matter decrease are consistent with those found in other 
chronic pain conditions. This grey matter alteration also seems to be a reflection of neurological 
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adaptation to a pain perception that is high level and frequent. This data provides the information 
needed to complete the first objective of this study.  
 Unlike what the researchers expected, there was no notable difference in grey matter 
between the two different categories of TN patients: those with constant background pain and 
those with intermittent attacks (Obermann, et. al, 2013). The scientists explain that the most 
logical reason for this finding is that the repeated attacks, though they are short, provide an 
amount of stimulation that is enough to cause grey matter changes in the brain.  
 As other studies have mentioned, it is unclear whether grey matter changes are due to 
atrophy of cells, changes in interstitial fluid, blood flow, or a change in cell size. VBM imaging 
does not allow scientists to determine the cause of grey matter decrease, only that it has occurred. 
The authors note that they cannot determine whether alterations in grey matter are due to a 
reversible process or an irreversible process without a histological analysis.  
 This study directly relates to the PICOT question because the researchers were able to 
link TN to a decrease in grey matter volume, but were not able to definitively say that it was a 
result of atrophy. The sample size recruited for this study was larger than some of the previous 
studies with 60 pain participants and 49 healthy controls. Though this study did determine that 
there was a change in grey matter with this chronic pain condition, their data didn’t reveal 
anything that previous research hadn’t already. This article was organized, easy to read, and well 
written.  
Gaps in Literature 
 At this time, this is no definitive research on the cause of grey matter decrease in chronic 
pain conditions. Though many articles refer to this decrease as atrophy, further research is 
needed to determine the true cause. There are many studies on this topic that have been 
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published in the last 20 years, however the most recent article that I discussed above was 
published in 2013. There is still much to be discovered on the deficits that chronic pain patients 
experience, why some patients will develop a chronic pain syndrome while others do not, and 
whether neurological changes in the chronic pain brain are permeant or reversible. 
Conclusion 
 Chronic pain can be difficult to manage and in many cases, has a large impact on the 
quality of a patient’s life. For nurses and other providers to give the best care possible, it is 
important to know as much as possible about the origins ad effects of chronic pain conditions. 
Based on the research available today, it is obvious that chronic pain influences the grey matter 
volume of the brain. There is still much to be learned about how this happens, what the long-
term effects are, and if the changes are permanent. Some authors state that the changes in grey 
matter are the result of atrophy, while others have shown that if the cause of the pain is taken 
away, that the effects partially reverse (Rodriquez-Raecke, et. al, 2013). With more insight into 
the causes of chronic pain conditions, there are opportunities for experts to develop new, and 
more effective treatment methods for patients in need.   
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